Modulating GPR139 activity could influence D2R signaling, suggesting a novel approach to managing motor symptoms or addressing the nonmotor symptoms associated with PD, such as mood disturbances or impulse control disorders. The gene discussed is GPR139; the disease is Parkinson disease.